Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium and potassium channels are integral membrane proteins that regulate the electrical excitability of gastrointestinal (GI) smooth muscle cells and interstitial cells of Cajal (ICCs) (Sanders, 2006, PubMed: 16461353). Sodium channels, notably the Nav1.5 isoform encoded by SCN5A, are responsible for the rapid depolarization phase of the action potential and play a role in setting the mechanical threshold for contraction (Strege et al., 2003, PubMed: 12606603). Potassium channels, including various voltage-gated (Kv) and calcium-activated (BK) types, facilitate membrane repolarization and help maintain the resting membrane potential to prevent spontaneous over-excitation (Thornbury et al., 1992, PubMed: 1311053). Together, these channels coordinate the rhythmic electrical slow waves that drive peristalsis and segmental contractions throughout the digestive tract (Beyder & Farrugia, 2012, PubMed: 22450343). Mutations or expression changes in these channels, particularly SCN5A, are associated with motility disorders such as irritable bowel syndrome (IBS) and gastroparesis (Beyder et al., 2014, PubMed: 24583444). Therapeutic modulation of these channels can alter GI transit times and visceral sensation, offering potential treatments for chronic constipation or diarrhea (Mazzone et al., 2011, PubMed: 21418342). However, because these channel families are also highly expressed in the heart and brain, achieving GI-specific effects without cardiac or neurological side effects is a significant pharmacological challenge (Farrugia, 2006, PubMed: 16814751).
Modulation of sodium and potassium ion flux across the cell membrane to regulate the frequency, amplitude, and propagation of electrical slow waves and action potentials in the gastrointestinal tract (Sanders et al., 2006, PubMed: 16461353).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated sodium and potassium channels in gastrointestinal smooth muscle (VGSC/VGKC).